Skip to main content

Find Clinical Trials

Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,152 public trials 551 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

NCT00315432

Conditions: Anemia, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: Not specified

View Trial Details

Completed

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

NCT00111280

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

NCT01190124

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

NCT00317902

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)

NCT00328549

Conditions: Anemia, Blood-Borne Infections, Communicable Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing

NCT00938899

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

NCT00225303

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains

NCT00964327

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00270010

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

NCT00270270

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details